Bluefin Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-68,300
Closed -$763K 536
2020
Q1
$763K Sell
68,300
-209,300
-75% -$39.4M 0.1% 146
2019
Q4
$190K Sell
277,600
-80,400
-22% -$14.5M 0.01% 380
2019
Q3
$720K Buy
+358,000
New +$58.3M 0.1% 146
2018
Q1
Sell
-44,900
Closed -$973K 634
2017
Q4
$973K Sell
44,900
-74,000
-62% -$13.3M 0.06% 169
2017
Q3
$1.1M Sell
118,900
-15,000
-11% -$3.49M 0.13% 140
2017
Q2
$682K Buy
133,900
+300
+0.2% +$70.5K 0.07% 201
2017
Q1
$1.3M Sell
133,600
-718,300
-84% -$167M 0.17% 89
2016
Q4
$16.7M Sell
851,900
-365,950
-30% -$75.8M 1.03% 11
2016
Q3
$36.9M Buy
+1,217,850
New +$298M 1.35% 7

Other funds holding AGN

Bluefin Capital Management's AGN Position: Q2 2020 in Review

Bluefin Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 38,645 shares — an estimated $6.84M sold.

Bluefin Capital Management first reported a position in AGN in Q4 2013 and held it in 11 quarters. The position peaked at $103M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bluefin Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 38,645 Allergan plc shares in Q2 2020, an estimated $6.84M.
  • Bluefin Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 11 quarters.
  • Bluefin Capital Management's Allergan plc position peaked at $103M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bluefin Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.